newsfilter
← Latest News
GlobeNewswire·

Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson's Disease

- Completed three successful GMP campaigns using suspension-based manufacturing process- All batches achieved target titers and have successfully completed fill and finish- Qualified Person (QP) certification of at least one batch of clinical trial mater